Boston Scientific Corporation (BSX) vs Elevance Health Inc. (ELV)
A side-by-side comparison of Boston Scientific Corporation and Elevance Health Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.
BSX
Boston Scientific Corporation
$46.73HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT
ELV
Elevance Health Inc.
$375.84HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT
Total return — BSX vs ELV
growth of $100 · dividends reinvested · last 25yBSX +304.6%ELV +2222.2%ELV compounded faster
Log scale — wide-divergence pair
BSX ELV
BSX vs ELV: by the numbers
- •ELV is the larger company ($81.51B vs $69.46B market cap).
- •ELV trades at the lower trailing earnings multiple (16.70 vs 19.00 P/E), one valuation lens rather than an overall verdict.
- •BSX converts more revenue to profit (17.48% vs 2.47% net margin).
- •BSX grew revenue faster over the past five years (13.40% vs 9.25% CAGR).
- •ELV pays a dividend (1.83% yield), while BSX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BSX | ELV |
|---|---|---|
| P/E ratio | 19.00 | 16.70 |
| Forward P/E | 14.11 | 13.85 |
| P/S ratio | 3.30 | 0.41 |
| P/B ratio | 2.70 | 1.82 |
| PEG ratio | 0.88 | 2.50 |
| EV / EBITDA | 14.14 | 12.72 |
| FCF yield | 4.93% | 7.68% |
Profitability
| Metric | BSX | ELV |
|---|---|---|
| Gross margin | 71.16% | 25.56% |
| Operating margin | 21.60% | 3.51% |
| Net margin | 17.48% | 2.47% |
| ROE | 14.19% | 11.06% |
| ROIC | 8.78% | 6.65% |
Dividends
| Metric | BSX | ELV |
|---|---|---|
| Dividend yield | N/A | 1.83% |
| Payout ratio | N/A | 27.24% |
Growth (annualized)
| Metric | BSX | ELV |
|---|---|---|
| Revenue CAGR (5Y) | 13.40% | 9.25% |
| EPS CAGR (5Y) | N/A | 6.67% |
| FCF CAGR (5Y) | 19.89% | -19.97% |
| Total return CAGR (5Y) | 0.49% | 1.02% |
Frequently asked
- Which has the lower trailing P/E, BSX or ELV?
- ELV has the lower trailing P/E: BSX trades at 19.00 and ELV at 16.70. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BSX or ELV?
- Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus ELV at 9.25%.
- Does BSX or ELV pay a bigger dividend?
- ELV pays a dividend (1.83% yield), while BSX has no payments in the available dividend history.
- Is BSX or ELV more profitable?
- BSX runs the higher net margin — BSX at 17.48% versus ELV at 2.47%.
- How have BSX and ELV total returns compared?
- Over the past 10 years, BSX delivered 6.76% and ELV delivered 12.63% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Boston Scientific P/E ratioElevance Health P/E ratioBoston Scientific dividend yieldElevance Health dividend yieldBoston Scientific ROEElevance Health ROEBoston Scientific operating marginElevance Health operating marginBoston Scientific revenue growthElevance Health revenue growthBoston Scientific free cash flowElevance Health free cash flow
Boston Scientific & Elevance Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.